Tecan Sues Invitae, Qiagen for Diagnostic-Test Patent Royalties

Tecan Group AG filed two lawsuits—one against Invitae Corp., another against Qiagen NV—alleging that their genetic sequencing kits and the personalized diagnostic tests that use them infringe as many as five patents.

Tecan Genomics Inc. filed the suits on Oct. 6 against multiple companies. In one complaint, it alleges infringement by Invitae and Danaher Corp.’s Integrated DNA Technologies Inc. of US Patent Nos. 10,036,012; 10,876,108; 9,546,399; 11,098,357; and 11,725,241.

Tecan’s separate complaint against Qiagen and three of its subsidiaries alleges infringement of all of those except the ’399 patent. All cases were ...